A clinicopathologic study of patients with hemorrhagic myocardial infarction treated with selective coronary thrombolysis with urokinase.
Jump to navigation
Jump to search
Target Article[edit | edit source]
A clinicopathologic study of patients with hemorrhagic myocardial infarction treated with selective coronary thrombolysis with urokinase.; H Fujiwara, T Onodera, M Tanaka, T Fujiwara, DJ Wuae; 1986; doi_citing_unknown
Retraction[edit | edit source]
The no reflow phenomenon: a time-limiting factor for reperfusion after coronary occlusionchar(39) ; John R Darsee Robert A Kloner; 11/01/1980
Citation piece[edit | edit source]
Note: Open to append information.